Label: MUCINEX INSTASOOTHE SORE THROAT PLUS SOOTHING COMFORT- hexylresorcinol lozenge
- NDC Code(s): 72854-261-14, 72854-261-20, 72854-261-40
- Packager: RB Health (US) LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated February 15, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient (in each lozenge)
- Purpose
- Uses
-
Warnings
Sore throat warning
If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting, consult a doctor promptly.
- Directions
- Other information
- Inactive ingredients
- Questions?
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL - 2.4 mg Pouch Bag
-
INGREDIENTS AND APPEARANCE
MUCINEX INSTASOOTHE SORE THROAT PLUS SOOTHING COMFORT
hexylresorcinol lozengeProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:72854-261 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HEXYLRESORCINOL (UNII: R9QTB5E82N) (HEXYLRESORCINOL - UNII:R9QTB5E82N) HEXYLRESORCINOL 2.4 mg Inactive Ingredients Ingredient Name Strength CORN SYRUP (UNII: 9G5L16BK6N) D&C YELLOW NO. 10 (UNII: 35SW5USQ3G) FD&C YELLOW NO. 6 (UNII: H77VEI93A8) HONEY (UNII: Y9H1V576FH) PROPYLENE GLYCOL (UNII: 6DC9Q167V3) SUCROSE (UNII: C151H8M554) WATER (UNII: 059QF0KO0R) Product Characteristics Color yellow Score no score Shape ROUND Size 18mm Flavor HONEY Imprint Code S Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72854-261-20 20 in 1 BAG 07/01/2021 1 1 in 1 POUCH; Type 0: Not a Combination Product 2 NDC:72854-261-40 40 in 1 BAG 07/01/2021 2 1 in 1 POUCH; Type 0: Not a Combination Product 3 NDC:72854-261-14 140 in 1 BAG 09/09/2024 3 1 in 1 POUCH; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M022 07/01/2021 Labeler - RB Health (US) LLC (081049410)